
908 Devices (NASDAQ: MASS)
908 Devices Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
908 Devices Company Info
908 Devices, Inc. engages in the development of measurement devices for chemical and biochemical analysis. It offers products using mass spectrometry technology, an analytical technique for measuring the mass of charged molecules that is used in chemical analysis laboratories for applications, such as safety and security, food science, biotechnology, clinical diagnostics, and controlling industrial processes. Its products include desktops and handhelds. The company was founded by Kevin J. Knopp, Miller Scott, Steve Araiza, Andrew Bartfay, Michael Jobin, Christopher D. Brown, and Christopher J. Petty in 2012 and is headquartered in Boston, MA.
News & Analysis
908 Devices (MASS) Q2 Revenue Jumps 14%
Why 908 Devices Stock Rocketed More Than 18% Higher This Week
2 Cathie Wood Stocks That Could Soar in 2024, According to Wall Street
Wall Street is uber-bullish on these two Ark Invest holdings.
Why 908 Devices Stock Is Sinking Today
Investors didn't like the medical device maker's update.
Why 908 Devices Stock Rocketed 15% Higher Today
The niche healthcare company delivers a pair of convincing beats in its fourth quarter results.
Valuation
Earnings Transcripts
908 Devices Inc. (MASS) Q2 2022 Earnings Call Transcript
MASS earnings call for the period ending June 30, 2022.
908 Devices Inc. (MASS) Q1 2022 Earnings Call Transcript
MASS earnings call for the period ending March 31, 2022.
908 Devices Inc. (MASS) Q4 2021 Earnings Call Transcript
MASS earnings call for the period ending December 31, 2021.
908 Devices Inc. (MASS) Q3 2021 Earnings Call Transcript
MASS earnings call for the period ending September 30, 2021.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.